Pensions risk: the downside of weight-loss drugs
The health benefits could be so extreme that it upends the annuity market, hitting retirement incomes and insurers
Read more at Financial Times
Topics
-
FBI warns about counterfeit versions of weight loss drugs
The FBI warns counterfeit versions of weight loss drugs drugs can cause significant health issues.ABC News - Mar. 14 -
Recently fired pregnant federal employees cope with loss of insurance
Many pregnant federal workers fired as part of recent DOGE cuts are now faced with complex challenges as they deal with the loss of their income and health insurance.NBC News - Mar. 11 -
This retirement strategy is a 'game changer' for single-income, married couples, advisor says
If you're a single-income, married couple, you could use a spousal IRA to save more for retirement. Here's what to know.CNBC - Mar. 7 -
Weight Loss Drug Will Be Offered for $499 a Month for Some Patients
Some commercially insured patients stand to save $150 per month on Wegovy, a popular obesity medication. Patients on Medicare and Medicaid are not eligible.The New York Times - Mar. 5 -
Healthy Returns: Wegovy is linked to an increased risk of hair loss, study suggests
Novo Nordisk's weight loss drug Wegovy is linked to an increased risk of hair loss, a study suggests. Meanwhile, Dexcom received a warning letter from FDA.CNBC - Mar. 11 -
Here's how a loss to the Sixers could benefit the OKC Thunder
Here's how a loss to the Philadelphia 76ers could benefit the Oklahoma City Thunder.Yahoo Sports - 6d -
Why a weight-loss drug could become a geopolitical bargaining chip
Ozempic might feature in US negotiations with Denmark over GreenlandFinancial Times - 4d -
Fact-Checking Dr. Oz’s Health Advice on Supplements, Weight Loss and More
We evaluated his claims about probiotics, weight loss, heart health and more.The New York Times - Mar. 14 -
ETFs set to be high on the menu for Hong Kong pension funds
Launch of digital retirement platform market creates opportunity, say industry expertsFinancial Times - Mar. 14
More from Financial Times
-
Reeves to unveil £2.2bn UK defence spending boost in Spring Statement
Chancellor seeks new cuts in Whitehall after UK fiscal watchdog questions size of planned savings on welfareFinancial Times - 2h -
US agrees maritime ceasefire deal with Ukraine and Russia
Kyiv says it will comply immediately with Black Sea plan but Moscow asks for additional conditionsFinancial Times - 7h -
Trumponomics is putting lipstick on a policy pig
How do technocrats expect the needed macroeconomic adjustments to occur?Financial Times - 10h -
A white-collar world without juniors?
Professional business models may need to change if novices lose the opportunities to learn and progress when AI takes over their workFinancial Times - 20h -
Trump widens war on legal industry with order targeting Jenner & Block
The White House says the law firm ‘abandoned the profession’s highest ideals’ and ‘condoned partisan lawfare’Financial Times - 4h
More in Business
-
U.S. Adds Export Restrictions to More Chinese Tech Firms Over Security Concerns
The additions included companies that are customers of Intel and Nvidia, and one firm that was the focus of a New York Times investigation last year.The New York Times - 1h -
US proposes new critical minerals deal to Ukraine, says Zelenskyy
Kyiv says Washington’s proposal would be ‘grand agreement’ but does not include taking over nuclear power plantsFinancial Times - 1h -
With 23andMe entering bankruptcy, here's how to delete your genetic data
Now that 23andMe has filed for bankruptcy, another company could take control of its genetic database.CNBC - 1h -
Google quantum exec says tech is '5 years out from a real breakout'
Julian Kelly, Google Quantum AI's director of hardware, told CNBC quantum computers may only be about five years from a breakthrough.CNBC - 2h -
Reeves to unveil £2.2bn UK defence spending boost in Spring Statement
Chancellor seeks new cuts in Whitehall after UK fiscal watchdog questions size of planned savings on welfareFinancial Times - 2h